Development of stability indicating HPTLC method for estimation of antihypertensive drug combination nifedipine and valsartan

References

• Sweetman Sean C. Martindale: The complete drug reference. 35th ed. London: Published by the Pharmaceutical press; 2007; p. 1213, 1217, 1277.
   Google Scholar
• O'Neil Maryadele J. The Merck Index. An Encyclopedia of chemicals drugs. 15th ed. Published by The Royal Society of Chemistry, Cambridge, UK; 2013; p. 6613, 10102.
   Google Scholar
• Rang HP, Dale MM, Riter MJ, et al. In pharmacology. 6th ed. London: Elsevier Health Sciences; 2007; p. 501–502.
   Google Scholar
• Tripathi KD. Essentials of medical pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd; 2008; p. 549–550, 482, 486, 549, 540, 543,323, 529.
   Google Scholar
• Yuan-Nan Ke K, Dong YG, Shu-Ping M, et al. Improved blood pressure control with Nifedipine Gits/Valsartan combination versus high-dose Valsartan monotherapy in mild-to-moderate hypertensive patients from Asia. J Cardiovasc Pharmacol Ther. 2012;30:326–332.
   Google Scholar
• Ikuo S, Takao S. Controlled release Nifedipine and Valsartan combination therapy in patients with essential hypertension: the Adalat cr and Valsartan cost-effectiveness combination (advance-combi) study. J Hypertens Res. 2006;29:789–796.
   Web of Science ®Google Scholar
• Bayer Healthcare AG. Study number: 14696, NCT01071122. 2013; p. 1–6.
   Google Scholar
• US Pharmacopeia 39 NF 34. The United State Pharmacopoeia Convention, Rockvill, vol. II. 2016; p. 5064, 5065, 5066, 6324, 6325, 6324, 6325.
   Google Scholar
• British Pharmacopoeia. British Pharmacopoeia Commission, vol. I. 2016; p. 187, 188, 1594, 1595, 1594, 1595.
   Google Scholar
• Abou-Auda H, Najjar T, Khamis K, et al. Liquid chromatographic assay of Nifedipine in human plasma and its application to pharmacokinetic studies. J Pharm Biomed Anal. 2000;22:241–249.
   PubMed Web of Science ®Google Scholar
• Kamble N, Asirvatham S. Analytical method development and validation of Nifedipine and Atenolol in a capsule formulation by RP-HPLC. Int J Pharm Res Biosci. 2014;3(6):347–361.
   Google Scholar
• Modi T, Patel B, Patel J. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of lignocaine HCl and nifedipine in cream. J Pharm Anal. 2016;5(1):1–37.
   Google Scholar
• Vidyadhara S, Sasidhar RLC, Praveen Kumar B, et al. Method development and validation for simultaneous estimation of Atenolol and Nifedipine in pharmaceutical dosage forms by RP-HPLC. Oriental J Chem. 2012;28(4):1691–1696.
   Google Scholar
• Asthana S, Kaur V, Chawla P, et al. Rapid and sensitive HPLC-UV method for simultaneous estimation of Nifedipine, Nateglinide and Lovastatin: quantitative application to polypill based synthetic ternary mixture. Int J PharmTech Res. 2010;2(1):682–688.
   Google Scholar
• Ramtek M, Kasture A, Dighade N. Development of high performance thin layer chromatographic method for simultaneous estimation of Atenolol and Nefidipine in combined dosage form. Asian J Chem. 2010;2(8):5951–5955.
   Google Scholar
• Indian Pharmacopoeia. Ministry of Health and Family Welfare, Indian Pharmacopoeia Commision, Ghaziabad, Vol. III. 2014; p. 2336, 2951, 2338, 2339, 2340, 2952, 2953, 2952, 2953.
   Google Scholar
• Sahu M, Prasad KD. Development and validation of analytical method for the estimation of Valsartan in pure and tablet dosage form by RP-HPLC method. Int J Res Pharm Chem. 2011;1(4):945–949.
   Google Scholar
• Ghanty S, Das R, Maiti S, et al. RP-HPLC Method for estimation of valsartan in solid oral dosage forms. J PharmSci Tech. 2014;3(2):88–91.
   Google Scholar
• Alexandar S, Kumudhavalli MV, Umamaheswari D, et al. A simple HPLC method for the estimation of Valsartan from rat plasma application to pharmacokinetic study. Int J Pharm Technol. 2016;8(3):15687–15697.
   Google Scholar
• Haque MA, Amrohi SH, Mohanty D, et al. Stability indicating RP-HPLC method for the estimation of Valsartan in pharmaceutical dosage form. Int Org Sci Res J Pharm. 2012;2(4):12–18.
   Google Scholar
• Bhavani K G, Srinivasu N, Nanduri G, et al. Development and validation of RP-LC method for simultaneous estimation of Amlodipine Besylate and Valsartan in bulk and its pharmaceutical formulations. J De Afrikana. 2016;3(4):262–273.
   Google Scholar
• Reddy DM, Rao PP, Ramachandran D. Stability indicating HPLC method for simultaneous estimation of Hydrochlorothioazide, Amlodipine and Valsartan in pharmaceutical dosage form. World J Pharm Sci. 2014; 2(12):1830–1836.
   Google Scholar
• Sridevi R, Mandal B, Navalgund SG. Stability-indicating HPLC method for the simultaneous determination of Valsartan and Ezetimibe in pharmaceuticals. Trop J Pharm Res. 2014;13(5):809–817.
   Web of Science ®Google Scholar
• Vaka S, Patel P. New method development and validation for the simultaneous estimation of Sacubitril and Valsartan in a bulk and pharmaceutical dosage forms. Int J Res. 2017;4:17–24.
   Google Scholar
• Rizwan SH, Sastry GV. Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of Aliskiren Hemifumarate and Valsartan in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2015;8:223–227.
   Google Scholar
• Kachave RN, Kale M, Wagh RD. Simultaneous estimation of Cilnidipine and Valsartan by RP-HPLC in tablet formulation. Eur J Anal Chem. 2016;11(5):245–253.
   Web of Science ®Google Scholar
• Bhaisare M, Sahu K, Karthikeyan C, et al. RP-HPLC method for simultaneous estimation of Amlodipine and Valsartan in tablet formulation and validation as per ICH guidelines. Latin Am J Pharm. 2011;30(2):342–346.
   Web of Science ®Google Scholar
• Godiyal S, Nihalani G, Qureshi R, et al. Development and validation of HPTLC method for estimation of Valsartan in bulk and marketed formulation. Indo-American J Pharm Res. 2016;6(8):6478–6484.
   Google Scholar
• Jadhav ML, Girase MV, Tidme SK. Development and validation of HPTLC method for simultaneous estimation of Valsartan and Hydrochlorothiazide in tablet dosage form. J Pharm BioSci. 2015;2:20–25.
   Google Scholar
• Lokhande SP, Gupta SP, Garg G, et al. Development and validation of a HPTLC method for the simultaneous estimation of Ramipril and Valsartan. Int J Pharm Teach Pract. 2012;3(1):225–227.
   Google Scholar
• Shah PM, Shah JS, Maheshwari DG. Development and validation RP-HPLC method for simultaneous estimation of Valsartan and Nifedipine in synthetic mixture. Int J Pharm Technol. 2016;7(2):9161–9169.
   Google Scholar
• Sood J, Sapra B, Tiwary A. Microemulsion transdermal formulation for simultaneous delivery of Valsartan and Nifedipine formulation by design. Am Assoc Pharm Sci. 2016;18 (6):1–16.
   Google Scholar
• Patel CB, Patel SA. Development and validation of Q-absorbance ratio method for simultaneous estimation of Valsartan and Nifedipine in synthetic mixture. Int Res J Pharm. 2016;7(1):1–8.
   Google Scholar